Desvenlafaxine Tablet, Extended Release
Product Images NDC 0591-3659

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Desvenlafaxine (NDC 0591-3659). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure diagram of desvenlafaxine, showing its molecular arrangement including hydroxyl groups, amine groups, and carboxyl groups, as well as associated water of hydration.*

FDA Label Image

Image 2

A forest plot depicting the geometric mean ratio with 90% confidence intervals for Cmax and AUC of Desvenlafaxine in subjects with varying degrees of renal and hepatic impairment and different population subgroups by gender and age. The x-axis represents change relative to reference, ranging from 0.5 to 3.5, with data points and confidence intervals plotted for each condition and subgroup.*

FDA Label Image

Image 3

A pharmacokinetic (PK) chart showing the geometric mean ratio with 90% confidence intervals of Desvenlafaxine in presence of the CYP3A4 inhibitor Ketoconazole. The chart compares changes in Cmax and AUC relative to a reference, indicating a Cmax ratio around 1.08 and an AUC ratio around 1.43.*

FDA Label Image

Image 4

A data table presenting geometric mean ratios with 90% confidence intervals depicting pharmacokinetic drug interactions of Desvenlafaxine extended-release (ER) tablets at strengths 50 mg, 100 mg, and 400 mg. It lists interacting drugs (Desipramine, Midazolam, Tamoxifen, Aripiprazole), the measured pharmacokinetic parameters (Cmax, AUC, AUCinf), and the degree of change due to Desvenlafaxine, shown graphically and numerically.*

FDA Label Image

Image 5

A Kaplan-Meier survival curve graph showing estimated proportion of patients with relapse (%) over time in days from randomization. The graph compares Desvenlafaxine Extended-Release Tablets 50 mg (solid line) versus placebo (dashed line). The Y-axis indicates proportion of patients with relapse, and the X-axis indicates time to relapse in days, up to 200 days.*

FDA Label Image

Image 6

A Kaplan-Meier survival curve comparing Desvenlafaxine extended-release tablets to placebo. The graph shows the estimated proportion of patients with relapse (%) on the y-axis and time to relapse in days from randomization on the x-axis, illustrating relapse rates over approximately 180 days for both groups.*

FDA Label Image

Image 7

Desvenlafaxine Extended-Release Tablets 25 mg film-coated tablets by Actavis Pharma, Inc. The label states dispensing instructions, storage conditions (20° to 25°C, with excursions to 15°-30°C), and dosage form as extended-release. Package contains 30 tablets and includes a barcode and serialization area. Manufacturer is Teva Pharmaceuticals, Parsippany, NJ.*

FDA Label Image

Image 8

Desvenlafaxine Extended-Release Tablets 50 mg label showing product name, strength, dosage form as extended-release tablets, and quantity of 30 tablets. Contains dosing instructions, storage conditions, and pharmacy dispensing guidance. Manufactured for Teva Pharmaceuticals.*

FDA Label Image

Image 9

Label for Desvenlafaxine extended-release tablets, 100 mg strength. The oral tablet packaging indicates 30 tablets per unit, labeled by Actavis Pharma, Inc. It includes storage instructions, dosage information, and a barcode on a white background with green and blue accents.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.